Stock DNA
Software Products
JPY 90,990 Million (Small Cap)
48.00
NA
0.00%
0.45
-999,999.00%
17.85
Revenue and Profits:
Net Sales:
8,005 Million
(Quarterly Results - Dec 2025)
Net Profit:
1,258 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
97.40%
EBIT Growth (5y)
184.52%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
Price to Book Value
16.35
EV to EBIT
34.53
EV to EBITDA
34.01
EV to Capital Employed
11.57
EV to Sales
6.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.49%
ROE (Latest)
33.77%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
14,206.00
7,061.20
101.18%
Operating Profit (PBDIT) excl Other Income
2,518.30
1,264.50
99.15%
Interest
26.40
20.30
30.05%
Exceptional Items
-26.10
-77.50
66.32%
Consolidate Net Profit
1,703.30
825.10
106.44%
Operating Profit Margin (Excl OI)
174.60%
178.00%
-0.34%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 101.18% vs 93.71% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 106.44% vs 412.07% in Mar 2024






